Peter C. Fineran

13.6k total citations · 4 hit papers
135 papers, 9.1k citations indexed

About

Peter C. Fineran is a scholar working on Molecular Biology, Ecology and Genetics. According to data from OpenAlex, Peter C. Fineran has authored 135 papers receiving a total of 9.1k indexed citations (citations by other indexed papers that have themselves been cited), including 101 papers in Molecular Biology, 74 papers in Ecology and 30 papers in Genetics. Recurrent topics in Peter C. Fineran's work include Bacteriophages and microbial interactions (73 papers), CRISPR and Genetic Engineering (73 papers) and Insect symbiosis and bacterial influences (29 papers). Peter C. Fineran is often cited by papers focused on Bacteriophages and microbial interactions (73 papers), CRISPR and Genetic Engineering (73 papers) and Insect symbiosis and bacterial influences (29 papers). Peter C. Fineran collaborates with scholars based in New Zealand, United Kingdom and Netherlands. Peter C. Fineran's co-authors include George P. C. Salmond, Bridget N. J. Watson, Raymond H.J. Staals, Hannah G. Hampton, Simon A. Jackson, Ron L. Dy, Corinna Richter, Neil R. Williamson, Chris M. Brown and Stan J. J. Brouns and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Peter C. Fineran

128 papers receiving 9.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The arms race between bacteria and their phage foes

2020 556 citations Hannah G. Hampton, Peter C. Fineran et al. Nature profile →
A century of the phage: past, present and future

2015 556 citations Peter C. Fineran et al. Nature Reviews Microbiology profile →
The phage abortive infection system, ToxIN, functions as a protein–RNA toxin–antitoxin pair

2009 412 citations Peter C. Fineran, Tim R. Blower et al. profile →
Inhibitors of bacterial immune systems: discovery, mechanisms and applications

2024 49 citations David Mayo-Muñoz, Rafael Pinilla‐Redondo et al. Nature Reviews Genetics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter C. Fineran New Zealand	53	6.1k	4.2k	2.0k	1.3k	1.3k	135	9.1k
Dominique Mengin‐Lecreulx France	59	5.2k 0.8×	1.4k 0.3×	3.0k 1.5×	633 0.5×	550 0.4×	167	10.1k
David Bikard France	35	6.2k 1.0×	1.9k 0.4×	2.0k 1.0×	847 0.6×	744 0.6×	63	7.6k
Colin Manoil United States	44	6.3k 1.0×	1.6k 0.4×	3.9k 2.0×	1.6k 1.2×	835 0.7×	85	9.1k
George F. Mayhew United States	20	5.7k 0.9×	1.9k 0.5×	3.5k 1.8×	2.1k 1.6×	915 0.7×	26	9.2k
Peter J. Christie United States	57	4.9k 0.8×	2.2k 0.5×	3.0k 1.5×	2.8k 2.1×	2.6k 2.0×	114	10.3k
Martin Hunt United Kingdom	32	3.6k 0.6×	1.4k 0.3×	464 0.2×	1.2k 0.9×	1.6k 1.3×	66	7.5k
Frank Kunst France	44	3.6k 0.6×	1.5k 0.4×	2.5k 1.3×	1.3k 1.0×	694 0.5×	76	7.4k
Didier Lereclus France	61	11.0k 1.8×	1.9k 0.5×	2.6k 1.3×	536 0.4×	2.6k 2.0×	172	12.5k
Margaret C. M. Smith United Kingdom	37	3.8k 0.6×	2.0k 0.5×	1.4k 0.7×	316 0.2×	861 0.7×	120	5.3k
Bernard Joris Belgium	45	3.9k 0.6×	889 0.2×	1.5k 0.8×	607 0.5×	1.5k 1.1×	186	8.3k

Countries citing papers authored by Peter C. Fineran

Since Specialization

Citations

This map shows the geographic impact of Peter C. Fineran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter C. Fineran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter C. Fineran more than expected).

Fields of papers citing papers by Peter C. Fineran

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter C. Fineran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter C. Fineran. The network helps show where Peter C. Fineran may publish in the future.

Co-authorship network of co-authors of Peter C. Fineran

This figure shows the co-authorship network connecting the top 25 collaborators of Peter C. Fineran. A scholar is included among the top collaborators of Peter C. Fineran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter C. Fineran. Peter C. Fineran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Meaden, Sean, Edze R. Westra, & Peter C. Fineran. (2025). Phage defence-system abundances vary across environments and increase with viral density. Philosophical Transactions of the Royal Society B Biological Sciences. 380(1934). 20240069–20240069.

Warring, Suzanne L., Dennis Grimon, Diana Gutiérrez, et al.. (2025). Engineering an antimicrobial chimeric endolysin that targets the phytopathogen Pseudomonas syringae pv. actinidiae. Journal of Biological Chemistry. 301(6). 110224–110224. 1 indexed citations

Liang, Cui, Leah Smith, Oliver Dietrich, et al.. (2025). Phage arabinosyl-hydroxy-cytosine DNA modifications result in distinct evasion and sensitivity responses to phage defense systems. Cell Host & Microbe. 33(7). 1173–1190.e9. 2 indexed citations

Smith, Leah & Peter C. Fineran. (2025). Type I CRISPR-Cas immunity primes type III spacer acquisition. Cell Host & Microbe. 33(9). 1561–1576.e6.

Lee, So Yeon, Nils Birkholz, Jun Hyuck Lee, Peter C. Fineran, & Hyun Ho Park. (2025). Regulation of anti-CRISPR operons by structurally distinct families of Aca proteins. Communications Biology. 8(1). 1698–1698.

Birkholz, Nils, Max E. Wilkinson, Christian Cuba Samaniego, et al.. (2024). Phage anti-CRISPR control by an RNA- and DNA-binding helix–turn–helix protein. Nature. 631(8021). 670–677. 12 indexed citations

Sitter, Thomas, Travis R. Glare, Murray P. Cox, et al.. (2024). Serratia‐based toxin cluster elements are associated with a type I fimbria. MicrobiologyOpen. 13(1).

Birkholz, Nils, et al.. (2024). Repurposing an Endogenous CRISPR-Cas System to Generate and Study Subtle Mutations in Bacteriophages. The CRISPR Journal. 7(6). 343–354. 1 indexed citations

Mayo-Muñoz, David, et al.. (2024). Inhibitors of bacterial immune systems: discovery, mechanisms and applications. Nature Reviews Genetics. 25(4). 237–254. 49 indexed citations breakdown →

10.

Wang, Cecilia, Chen‐Yi Cheung, Boatema Ofori-Anyinam, et al.. (2024). Whole genome CRISPRi screening identifies druggable vulnerabilities in an isoniazid resistant strain of Mycobacterium tuberculosis. Nature Communications. 15(1). 9791–9791. 12 indexed citations

11.

Jackson, Simon A., et al.. (2023). Genome sequences of Mx1, the first Myxococcus phage isolated, and Mx4, a generalized transducing myxophage. Microbiology Resource Announcements. 12(12). e0090423–e0090423. 1 indexed citations

12.

Birkholz, Nils, Simon A. Jackson, Robert D. Fagerlund, & Peter C. Fineran. (2022). A mobile restriction–modification system provides phage defence and resolves an epigenetic conflict with an antagonistic endonuclease. Nucleic Acids Research. 50(6). 3348–3361. 31 indexed citations

13.

Mayo-Muñoz, David, Leah Smith, Carmela Garcia‐Doval, et al.. (2022). Type III CRISPR-Cas provides resistance against nucleus-forming jumbo phages via abortive infection. Molecular Cell. 82(23). 4471–4486.e9. 35 indexed citations

14.

Payne, Leighton, Sean Meaden, Mario Rodríguez Mestre, et al.. (2022). PADLOC: a web server for the identification of antiviral defence systems in microbial genomes. Nucleic Acids Research. 50(W1). W541–W550. 102 indexed citations

15.

Pinilla‐Redondo, Rafael, Jakob Russel, David Mayo-Muñoz, et al.. (2021). CRISPR-Cas systems are widespread accessory elements across bacterial and archaeal plasmids. Nucleic Acids Research. 50(8). 4315–4328. 61 indexed citations

16.

Malone, Lucía M., Hannah G. Hampton, Xochitl C. Morgan, & Peter C. Fineran. (2021). Type I CRISPR-Cas provides robust immunity but incomplete attenuation of phage-induced cellular stress. Nucleic Acids Research. 50(1). 160–174. 19 indexed citations

17.

Pinilla‐Redondo, Rafael, Nicole D. Marino, Robert D. Fagerlund, et al.. (2020). Discovery of multiple anti-CRISPRs highlights anti-defense gene clustering in mobile genetic elements. Nature Communications. 11(1). 105 indexed citations

18.

Westra, Edze R., Angus Buckling, & Peter C. Fineran. (2014). CRISPR–Cas systems: beyond adaptive immunity. Nature Reviews Microbiology. 12(5). 317–326. 237 indexed citations

19.

Fineran, Peter C. & Emmanuelle Charpentier. (2012). Memory of viral infections by CRISPR-Cas adaptive immune systems: Acquisition of new information. Virology. 434(2). 202–209. 178 indexed citations

20.

Przybilski, Rita, et al.. (2011). Csy4 is responsible for CRISPR RNA processing inPectobacterium atrosepticum. RNA Biology. 8(3). 517–528. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact